Viridian Therapeutics, Inc./DE Notes Payable, Current
Viridian Therapeutics, Inc./DE (VRDN) had Notes Payable, Current of $0 as of 2020-12-31, per its 10-K filed 2021-03-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2021-03-26
- 2020-12-31: Notes Payable, Current $0.00.
- 2020-09-30: Notes Payable, Current $4.71M.
- 2020-06-30: Notes Payable, Current $3.42M.
- 2020-03-31: Notes Payable, Current $3.98M.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-26 | |
| 2020-09-30 | $4.71M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.42M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $3.98M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $3.98M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $3.97M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $3.97M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.30M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.29M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $1.29M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $289.00K 10-Q · filed 2018-08-08 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 | |
| 2017-09-30 | $1.98M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.98M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $1.97M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $1.97M 10-K · filed 2018-03-15 | |
| 2014-09-30 | $10.60K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $10.60K 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $42.00K 10-K · filed 2015-03-27 | $42.05K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |